Bristol-Myers Squibb BMY Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's short-term investments?
- Bristol-Myers Squibb (BMY) reported short-term investments of $2.35B in Q2 2026.
- How has Bristol-Myers Squibb's short-term investments changed year-over-year?
- Bristol-Myers Squibb's short-term investments increased by 133.6% year-over-year, from $1B to $2.35B.
- What is the long-term trend for Bristol-Myers Squibb's short-term investments?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's short-term investments has grown at a -18.4% compound annual growth rate (CAGR), from $1.29B to $464M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.